 Oral tocolysis magnesium chloride prospective clinical trial prospective clinical trial efficacy safety enteric-coated magnesium chloride SLOW MAG oral tocolytic agent Seventy-five patients weeks gestation intravenous magnesium sulfate first episode preterm labor contraction-free period intravenous therapy patients sealed envelope groups group SLOW MAG mg hours group oral ritodrine mg hours group therapy control Patients oral therapy delivery completion weeks gestation difference groups respect time use oral therapy number weeks gestation Therapy enteric-coated magnesium chloride side effects ritodrine results ritodrine enteric-coated magnesium chloride effective pregnancy recurrent preterm labor enteric-coated magnesium chloride ritodrine effective prevention preterm delivery observation